PL3035965T4

Bi-specific monovalent diabodies that are capable of binding cd123 and cd3, and uses therof

Abstract

This record has no abstract on file.

Term

7.9 yearsto projected expiry

Projected expiry 20 August 2034, counted from filing; an application has no term until it is granted.

  1. Priority
  2. Filed
  3. Published
  4. Today
  5. Projected expiry

60 members in 38 offices

This recordMember, by publication datePriority claim28 more offices are in the list below

Priority claims5

Priority claims
DocumentOfficeKindDate
201361869510United States of AmericaP
201361907749United States of AmericaP
13198784European Patent Office (EPO)A
201461990475United States of AmericaP
2014051790United States of AmericaW

Members60

Family members, oldest first
DocumentOfficeKind
EP2839842A1European Patent Office (EPO)A1
CA2920116A1CanadaA1
WO2015026892A1World Intellectual Property Organization (WIPO)A1
TW201542593ATaiwan Province of ChinaA
AP2016009029A0African Regional Intellectual Property Organization (ARIPO)A0
AR097405A1ArgentinaA1
AU2014308905A1AustraliaA1
SG11201601317UASingaporeA
IL244237A0IsraelA0
IL244237D0IsraelD0
KR20160045134ARepublic of KoreaA
PH12016500311A1PhilippinesA1
PH12016500311B1PhilippinesB1
PE20160509A1PeruA1
MX2016002260AMexicoA
EP3035965A1European Patent Office (EPO)A1
CR20160108ACosta RicaA
US2016200827A1United States of AmericaA1
CN105873607AChinaA
EA201690443A1Eurasian Patent Organization (EAPO)A1
CL2016000362A1ChileA1
JP2017504577AJapanA
EP3035965A4European Patent Office (EPO)A4
TN2016000046A1TunisiaA1
ZA201600653BSouth AfricaB
HK1225999AHong Kong, ChinaA
HK1225999A1Hong Kong, ChinaA1
US9822181B2United States of AmericaB2
BR112016003417A2BrazilA2
US2018094072A1United States of AmericaA1
AU2014308905B2AustraliaB2
JP6524087B2JapanB2
UA119539C2UkraineC2
TWI669310BTaiwan Province of ChinaB
GEP20197053BGeorgiaB
EA034142B1Eurasian Patent Organization (EAPO)B1
CN105873607BChinaB
MX373374BMexicoB
IL244237AIsraelA
IL244237BIsraelB
US10787521B2United States of AmericaB2
EP3035965B1European Patent Office (EPO)B1
DK3035965T3DenmarkT3
US2021047426A1United States of AmericaA1
PT3035965TPortugalT
RS61522B1SerbiaB1
LT3035965TLithuaniaT
HRP20210215T1CroatiaT1
EP3808776A1European Patent Office (EPO)A1
SMT202100123T1San MarinoT1
PL3035965T3PolandT3
PL3035965T4This recordPolandT4
SI3035965T1SloveniaT1
KR102287523B1Republic of KoreaB1
HUE054315T2HungaryT2
SA516370567B1Saudi ArabiaB1
SA8650B1Saudi ArabiaB1
NZ716914ANew ZealandA
ES2860973T3SpainT3
CY1123940T1CyprusT1